Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_assertion description "[The CD34+ restricted pattern of expression of CML28 and CML66 is particularly relevant in light of the notion that DLI likely exerts its curative effect by targeting antigens present in self-renewing malignant progenitor populations in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_assertion evidence source_evidence_literature NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_assertion SIO_000772 15958636 NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_assertion wasDerivedFrom befree-2016 NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_assertion wasGeneratedBy ECO_0000203 NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.
- befree-2016 importedOn "2016-02-19" NP499800.RAdWguY4tf_DQfhigfCxxGmVpw-AqRLe2M6gkO4LZEijM130_provenance.